Zhang YY - Search Results

1

Tumor iron homeostasis and immune regulation.

Zhang YY, Han Y, Li WN, Xu RH, Ju HQ. Zhang YY, et al. Trends Pharmacol Sci. 2024 Feb;45(2):145-156. doi: 10.1016/j.tips.2023.12.003. Epub 2024 Jan 11. Trends Pharmacol Sci. 2024. PMID: 38212195 Review.

2

IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance.

Han Y, Zhang YY, Pan YQ, Zheng XJ, Liao K, Mo HY, Sheng H, Wu QN, Liu ZX, Zeng ZL, Yang W, Yuan SQ, Huang P, Ju HQ, Xu RH. Han Y, et al. Among authors: zhang yy. Mol Cell. 2023 Jun 1;83(11):1887-1902.e8. doi: 10.1016/j.molcel.2023.05.011. Epub 2023 May 26. Mol Cell. 2023. PMID: 37244254 Free article.

3

Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism.

Han Y, Chen P, Zhang Y, Lu W, Ding W, Luo Y, Wen S, Xu R, Liu P, Huang P. Han Y, et al. Cancers (Basel). 2019 Jul 3;11(7):931. doi: 10.3390/cancers11070931. Cancers (Basel). 2019. PMID: 31277230 Free PMC article.

4

Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo.

Liu X, Zhang Y, Lu W, Han Y, Yang J, Jiang W, You X, Luo Y, Wen S, Hu Y, Huang P. Liu X, et al. Redox Biol. 2020 Sep;36:101652. doi: 10.1016/j.redox.2020.101652. Epub 2020 Jul 23. Redox Biol. 2020. PMID: 32750669 Free PMC article.

5

Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD-L1 and predicts poor prognosis in B-cell lymphoma.

Liu X, Zhang Y, Han Y, Lu W, Yang J, Tian J, Sun P, Yu T, Hu Y, Zhang H, Huang P, Liu P. Liu X, et al. Mol Oncol. 2020 May;14(5):1028-1044. doi: 10.1002/1878-0261.12664. Epub 2020 Apr 13. Mol Oncol. 2020. PMID: 32157792 Free PMC article.

6

Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma.

Deng H, Kan A, Lyu N, Mu L, Han Y, Liu L, Zhang Y, Duan Y, Liao S, Li S, Xie Q, Gao T, Li Y, Zhang Z, Zhao M. Deng H, et al. Liver Cancer. 2020 Jun;9(3):338-357. doi: 10.1159/000505695. Epub 2020 Feb 25. Liver Cancer. 2020. PMID: 32647635 Free PMC article.

7

Integrative Analysis Reveals Comprehensive Altered Metabolic Genes Linking with Tumor Epigenetics Modification in Pan-Cancer.

Shi Y, Wei J, Chen Z, Yuan Y, Li X, Zhang Y, Meng Y, Hu Y, Du H. Shi Y, et al. Biomed Res Int. 2019 Nov 7;2019:6706354. doi: 10.1155/2019/6706354. eCollection 2019. Biomed Res Int. 2019. PMID: 31828117 Free PMC article.

8

Oncogenic K-ras Induces Mitochondrial OPA3 Expression to Promote Energy Metabolism in Pancreatic Cancer Cells.

Meng N, Glorieux C, Zhang Y, Liang L, Zeng P, Lu W, Huang P. Meng N, et al. Cancers (Basel). 2019 Dec 25;12(1):65. doi: 10.3390/cancers12010065. Cancers (Basel). 2019. PMID: 31881642 Free PMC article.

9

Multiphase and multiparameter MRI-based radiomics for prediction of tumor response to neoadjuvant therapy in locally advanced rectal cancer.

Huang H, Han L, Guo J, Zhang Y, Lin S, Chen S, Lin X, Cheng C, Guo Z, Qiu Y. Huang H, et al. Radiat Oncol. 2023 Oct 31;18(1):179. doi: 10.1186/s13014-023-02368-4. Radiat Oncol. 2023. PMID: 37907928 Free PMC article.

10

Pretreatment MRI-Based Radiomics for Prediction of Rectal Cancer Outcome: A Discovery and Validation Study.

Huang H, Han L, Guo J, Zhang Y, Lin S, Chen S, Lin X, Cheng C, Guo Z, Qiu Y. Huang H, et al. Acad Radiol. 2024 May;31(5):1878-1888. doi: 10.1016/j.acra.2023.10.055. Epub 2023 Nov 22. Acad Radiol. 2024. PMID: 37996362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,247 results

Search Page

Filters